Dominic Cushnan

Dominic Cushnan

Auto-generated profile, based on publicly available information

Dominic Cushnan

NHS England, London, England

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Digital Health
Verified
Journal Article
Open access
PDF file
DCDominic Cushnan
Dominic Cushnan
RBRosalind Berka
Rosalind Berka
OBOttavia Bertolli
Ottavia Bertolli
PWPeter Williams
Peter Williams
DSDaniel Schofield
Daniel Schofield
JJJoseph Jacob
Joseph Jacob
The prevalence of the coronavirus SARS-CoV-2 disease has resulted in the unprecedented collection of health data to support research. Historically, coordinating the collation of such datasets on a national scale has been challenging to execute for several reasons, including issues with data privacy, the lack of data reporting standards, interoperable technologies, and distribution methods. The coronavirus SARS-CoV-2 disease pandemic has highlighted the importance of collaboration between government bodies, healthcare institutions, academic researchers and commercial companies in overcoming these issues during times of urgency. The National COVID-19 Chest Imaging Database, led by NHSX, British Society of Thoracic Imaging, Royal Surrey NHS Foundation Trust and Faculty, is an example of such a national initiative. Here, we summarise the experiences and challenges of setting up the National COVID-19 Chest Imaging Database, and the implications for future ambitions of national data curation in medical imaging to advance the safe adoption of artificial intelligence in healthcare.

25 November 2021 in GigaScience
Verified
Journal Article
Open access
PDF file
DCDominic Cushnan
Dominic Cushnan
OBOscar Bennett
Oscar Bennett
RBRosalind Berka
Rosalind Berka
OBOttavia Bertolli
Ottavia Bertolli
ACAshwin Chopra
Ashwin Chopra
NCNCCID Collaborative
NCCID Collaborative
Background: The National COVID-19 Chest Imaging Database (NCCID) is a centralized database containing mainly chest X-rays and computed tomography scans from patients across the UK. The objective of the initiative is to support a better understanding of the coronavirus SARS-CoV-2 disease (COVID-19) and the development of machine learning technologies that will improve care for patients hospitalized with a severe COVID-19 infection. This article introduces the training dataset, including a snapshot analysis covering the completeness of clinical data, and availability of image data for the various use-cases (diagnosis, prognosis, longitudinal risk). An additional cohort analysis measures how well the NCCID represents the wider COVID-19–affected UK population in terms of geographic, demographic, and temporal coverage. Findings: The NCCID offers high-quality DICOM images acquired across a variety of imaging machinery; multiple time points including historical images are available for a subset of patients. This volume and variety make the database well suited to development of diagnostic/prognostic models for COVID-associated respiratory conditions. Historical images and clinical data may aid long-term risk stratification, particularly as availability of comorbidity data increases through linkage to other resources. The cohort analysis revealed good alignment to general UK COVID-19 statistics for some categories, e.g., sex, whilst identifying areas for improvements to data collection methods, particularly geographic coverage. Conclusion: The NCCID is a growing resource that provides researchers with a large, high-quality database that can be leveraged both to support the response to the COVID-19 pandemic and as a test bed for building clinically viable medical imaging models.

4 January 2024 in JMIR AI
Verified
Journal Article
Open access
KKKassandra Karpathakis
Kassandra Karpathakis
EPEmma Pencheon
Emma Pencheon
DCDominic Cushnan
Dominic Cushnan
Background: The COVID-19 pandemic drove investment and research into medical imaging platforms to provide data to create artificial intelligence (AI) algorithms for the management of patients with COVID-19. Building on the success of England’s National COVID-19 Chest Imaging Database, the national digital policy body (NHSX) sought to create a generalized national medical imaging platform for the development, validation, and deployment of algorithms. Objective: This study aims to understand international use cases of medical imaging platforms for the development and implementation of algorithms to inform the creation of England’s national imaging platform. Methods: The National Health Service (NHS) AI Lab Policy and Strategy Team adopted a multiphased approach: (1) identification and prioritization of national AI imaging platforms; (2) Political, Economic, Social, Technological, Legal, and Environmental (PESTLE) factor analysis deep dive into national AI imaging platforms; (3) semistructured interviews with key stakeholders; (4) workshop on emerging themes and insights with the internal NHSX team; and (5) formulation of policy recommendations. Results: International use cases of national AI imaging platforms (n=7) were prioritized for PESTLE factor analysis. Stakeholders (n=13) from the international use cases were interviewed. Themes (n=8) from the semistructured interviews, including interview quotes, were analyzed with workshop participants (n=5). The outputs of the deep dives, interviews, and workshop were synthesized thematically into 8 categories with 17 subcategories. On the basis of the insights from the international use cases, policy recommendations (n=12) were developed to support the NHS AI Lab in the design and development of the English national medical imaging platform. Conclusions: The creation of AI algorithms supporting technology and infrastructure such as platforms often occurs in isolation within countries, let alone between countries. This novel policy research project sought to bridge the gap by learning from the challenges, successes, and experience of England’s international counterparts. Policy recommendations based on international learnings focused on the demonstrable benefits of the platform to secure sustainable funding, validation of algorithms and infrastructure to support in situ deployment, and creating wraparound tools for nontechnical participants such as clinicians to engage with algorithm creation. As health care organizations increasingly adopt technological solutions, policy makers have a responsibility to ensure that initiatives are informed by learnings from both national and international initiatives as well as disseminating the outcomes of their work.

3 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
DCDominic Cushnan
Dominic Cushnan
OBOscar Bennett
Oscar Bennett
RBRosalind Berka
Rosalind Berka
OBOttavia Bertolli
Ottavia Bertolli
ACAshwin Chopra
Ashwin Chopra
JWJeremy C Wyatt
Jeremy C Wyatt
The National COVID-19 Chest Imaging Database (NCCID) is a centralised database containing chest X-rays, chest Computed Tomography (CT) scans and cardiac Magnetic Resonance Images (MRI) from patients across the UK, jointly established by NHSX, the British Society of Thoracic Imaging (BSTI), Royal Surrey NHS Foundation Trust (RSNFT) and Faculty. The objective of the initiative is to support a better understanding of the coronavirus SARS-CoV-2 disease (COVID-19) and development of machine learning (ML) technologies that will improve care for patients hospitalised with a severe COVID-19 infection. The NCCID is now accumulating data from 20 NHS Trusts and Health Boards across England and Wales, with a total contribution of approximately 25,000 imaging studies in the training set (at time of writing) and is actively being used as a research tool by several organisations. This paper introduces the training dataset, including a snapshot analysis performed by NHSX covering: the completeness of clinical data, the availability of image data for the various use-cases (diagnosis, prognosis and longitudinal risk) and potential model confounders within the imaging data. The aim is to inform both existing and potential data users of the NCCID’s suitability for developing diagnostic/prognostic models. In addition, a cohort analysis was performed to measure the representativeness of the NCCID to the wider COVID-19 affected population. Three major aspects were included: geographic, demographic and temporal coverage, revealing good alignment in some categories, e.g., sex and identifying areas for improvements to data collection methods, particularly with respect to geographic coverage. All analyses and discussions are focused on the implications for building ML tools that will generalise well to the clinical use cases.

23 July 2023 in JMIR Preprints
Verified
Preprint
Open access
KKKassandra Karpathakis
Kassandra Karpathakis
EPEmma Pencheon
Emma Pencheon
DCDominic Cushnan
Dominic Cushnan
BACKGROUND The COVID-19 pandemic drove investment and research into medical imaging platforms to provide data to create artificial intelligence (AI) algorithms for the management of patients with COVID-19. Building on the success of England’s National COVID-19 Chest Imaging Database, the national digital policy body (NHSX) sought to create a generalized national medical imaging platform for the development, validation, and deployment of algorithms. OBJECTIVE This study aims to understand international use cases of medical imaging platforms for the development and implementation of algorithms to inform the creation of England’s national imaging platform. METHODS The National Health Service (NHS) AI Lab Policy and Strategy Team adopted a multiphased approach: (1) identification and prioritization of national AI imaging platforms; (2) Political, Economic, Social, Technological, Legal, and Environmental (PESTLE) factor analysis deep dive into national AI imaging platforms; (3) semistructured interviews with key stakeholders; (4) workshop on emerging themes and insights with the internal NHSX team; and (5) formulation of policy recommendations. RESULTS International use cases of national AI imaging platforms (n=7) were prioritized for PESTLE factor analysis. Stakeholders (n=13) from the international use cases were interviewed. Themes (n=8) from the semistructured interviews, including interview quotes, were analyzed with workshop participants (n=5). The outputs of the deep dives, interviews, and workshop were synthesized thematically into 8 categories with 17 subcategories. On the basis of the insights from the international use cases, policy recommendations (n=12) were developed to support the NHS AI Lab in the design and development of the English national medical imaging platform. CONCLUSIONS The creation of AI algorithms supporting technology and infrastructure such as platforms often occurs in isolation within countries, let alone between countries. This novel policy research project sought to bridge the gap by learning from the challenges, successes, and experience of England’s international counterparts. Policy recommendations based on international learnings focused on the demonstrable benefits of the platform to secure sustainable funding, validation of algorithms and infrastructure to support in situ deployment, and creating wraparound tools for nontechnical participants such as clinicians to engage with algorithm creation. As health care organizations increasingly adopt technological solutions, policy makers have a responsibility to ensure that initiatives are informed by learnings from both national and international initiatives as well as disseminating the outcomes of their work.

1 December 2021 in GigaScience
Verified
Journal Article
Open access
PDF file
DCDominic Cushnan
Dominic Cushnan
OBOscar Bennett
Oscar Bennett
RBRosalind Berka
Rosalind Berka
OBOttavia Bertolli
Ottavia Bertolli
ACAshwin Chopra
Ashwin Chopra
NCN C C I D Collaborative
N C C I D Collaborative
In the final publication of “An overview of the National COVID-19 Chest Imaging Database: data quality and cohort analysis” by Dominic Cushnan et al., figure 9 was erroneously duplicated in place of figure 8. Figure 8 (“comparison of sex split within (A) the NCCID COVID-19 patients, the general UK population (as reported in the 2011 census), and COVID-19 hospital admissions (reported by ISARIC); (B) NCCID recorded deaths and NHS England COVID-19 hospital mortality data”) now appears correctly in the article.